Publication | Closed Access

Immunogenicity and reactogenicity of a novel hexavalent DTPa-HBV-IPV/Hib vaccine compared to separate concomitant injections of DTPa-IPV/Hib and HBV vaccines, when administered according to a 3, 5 and 11 month vaccination schedule

VaccinationVaccine DevelopmentVaccine TargetImmunologyConcomitant InjectionsHepatitisVirologyHbv VaccinesPolyvalent VaccineMedicineVaccine ResearchMonth Vaccination Schedule